Clinical Trials Directory

Trials / Completed

CompletedNCT03866291

ESBL in Patients Returning to Sweden With Traveller's Diarrhoea

ESBL-producing Enterobacteriaceae in Patients With Traveller's Diarrhoea- a Prospective Cohort Study.

Status
Completed
Phase
Study type
Observational
Enrollment
305 (actual)
Sponsor
Lund University · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

Patients with traveller's diarrhoea frequently harbour Extended Spectrum Betalactamase (ESBL)-producing Enterobacteriaceae (EPE) returning from EPE-endemic areas. This study investigates to what extent travellers returning to Sweden with traveller's diarrhoea carry ESBL in their stool. The isolates are examined further according to species, phenotype, antibiogram and whole genome sequencing.

Detailed description

Samples sent to the department of clinical microbiology in Lund, Sweden for culture of salmonella, shigella, yersinia or campylobacter are also cultured selectively for ESBL. All patients are contacted by mail with the results. ESBL-positive patients are invited to submit further faecal cultures and blood samples during one year follow up time, to investigate how long the patient is colonized with ESBL.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention, observationalSee above

Timeline

Start date
2017-02-01
Primary completion
2019-06-20
Completion
2019-06-20
First posted
2019-03-07
Last updated
2019-07-02

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT03866291. Inclusion in this directory is not an endorsement.